Better Context Better Decisions

Context counts in life sciences. The Celltelligence analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access can use our library to search all of the content already delivered to their inbox. If you think a colleague would enjoy receiving our content, reach out to the Celltelligence team to make it happen.

Free
Posted in: Autologous, CAR-T, CD19 Feb 09 | 2024Autolus and BioNTech Enter into Strategic AllianceAccess Free Blast
Free
Posted in: Autologous, BCMA, CAR-T, CD19, Dual/triple agonist Jan 30 | 2024Gracell’s GC012F Receives IND Clearance in Early Line MMAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T, CD19, TCR Jan 12 | 2024JPM 2024 Analysis Day 4: Adaptimmune and CaribouAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T, CD19 Jan 12 | 2024JPM 2024 Analysis Days 2 & 3: Imugene, CRISPR Tx, and PrecigenAccess Free Blast
Free
Posted in: Allogeneic, CAR-T, CD19 Jan 11 | 2024JPM 2024 Analysis Day 3: AllogeneAccess Free Blast
1 2 3 31

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.